395.4500 -2.90 (-0.73%)
NSE Dec 26, 2025 15:31 PM
Volume: 2.0M
 

logo
Biocon Ltd.
12 Nov 2024
395.45
-0.73%
Sharekhan
Revenues stood at Rs. 3,590 crore, up 4% y-o-y and a 5% rise q-o-q. EBITDA reached Rs. 730 crore, down 1% y-o-y but up 24% q-o-q. PAT stood at Rs. 27 crore, a decline of 84% y-o-y and 97% q-o-q.
ICICI Direct downgraded Biocon Ltd. to Sell with a price target of 350.0 on 10 Dec, 2025.
More from Biocon Ltd.
Recommended